Riskpilot← Back to searchSign inGet full accessDrug Development Consulting Holding ApS
APSActiveCVR 42285722Smedeland 36Activities of holding companies · NACE 6421Est. 2021— employees
Revenue 2024
DKK -116K
+118% vs 2023
EBITDA margin
100.0%
-118% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
DKK -13,3M
-42% vs 2023
| Revenue | DKK -116K | +118% |
| EBITDA | DKK -116K | -118% |
| Net profit | DKK -13,3M | -42% |
| Total assets | DKK 79,2M | +12% |
| Equity | DKK 79,1M | +12% |
| Employees | — | — |
Legal name
Drug Development Consulting Holding ApS
CVR number
42285722
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
7. april 2021
Share capital
DKK 354.600
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse, af to medlemmer af bestyrelsen eller af en direktør i forening med bestyrelsens formand.
Company purpose
Selskabets formål er at eje kapitalandele i andre selskaber og anden i forbindelse hermed stående virksomhed, inklusiv, men ikke begrænset til, at yde management services til selskaber ejet fuldt eller delvist af selskabet.
Address
Smedeland 36
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 40 | -58 | -53 | -116 |
| Staff expenses | -0 | -0 | -0 | -0 |
| EBITDA | 40 | -58 | -53 | -116 |
| Depreciation & amort. | -0 | -0 | -0 | -0 |
| EBIT | 40 | -58 | -53 | -116 |
| Net financials | -15.752 | -11.814 | -9.329 | -13.211 |
| Profit before tax | -15.712 | -11.872 | -9.382 | -13.327 |
| Tax | -0 | 2 | -6 | -25 |
| Net profit | -15.712 | -11.874 | -9.376 | -13.302 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 70.809 | 72.021 | 70.482 | 79.167 |
| Equity | 70.809 | 71.988 | 70.460 | 79.145 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 33 | 22 | 22 |
| Total debt | 0 | 33 | 22 | 22 |
EBITDA margin
-11600000.0%
This company
15.8%
Market median
-73417822% vs market
20212024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20212024
Return on equity
-16.8%
This company
18.4%
Market median
-191% vs market
20212024
Net profit margin
-1330200000.0%
This company
8.1%
Market median
-16422222322% vs market
20212024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-04-07 – 2021-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JM Management | Management | 2021 | — | — |
| Founder | 2021 | — | — | |
RK Management | Management | 2023 | — | — |
RH Management | Management | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 66.7% | 66.7% | 2024 | |
DDC Mørk Holding ApS | Company | 15.0% | 15.0% | 2022 |
MØRK HOLDING 2007 ApS | Company | 25.0% | 25.0% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DDC Mørk Holding ApS
Drug Development Consulting Holding ApS Board members of Drug Development Consulting Holding ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jasper Michiel van Gorp | Management | 0 companies |
| Coöperatieve Gilde Healthcare Services III U.A. | Founder | 0 companies |
| Rasmus Koch Nelund | Management | 0 companies |
| René Holmen Pedersen | Management | 0 companies |
| Rafael Natanek | Board of Directors | 0 companies |
| Mette Kirstine Agger | Board of Directors | 0 companies |
| Niels Peder Nielsen | Chairman | 0 companies |
| Alejandra Maria Cristina Bonifacini Mørk | Board of Directors | 0 companies |
| Redmar Koene | Board of Directors | 0 companies |